Future Fund LLC Charles River Laboratories International, Inc. Transaction History

Future Fund LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$194.44 - $217.61 $23,916 - $26,766	-123 Reduced 7.01%	1,632 $319,000
Q2 2023 Aug 14, 2023	BUY	$183.71 - $210.25 $92,038 - $105,335	501 Added 39.95%	1,755 $368,000
Q1 2023 May 15, 2023	SELL	$191.89 - $259.92 $39,913 - $54,063	-208 Reduced 14.23%	1,254 $253,000
Q4 2022 Feb 10, 2023	BUY	$197.11 - $250.07 $10,249 - $13,003	52 Added 3.69%	1,462 $318,000
Q3 2022 Nov 17, 2022	SELL	$182.44 - $250.54 $9,851 - $13,529	-54 Reduced 3.69%	1,410 $277,000
Q2 2022 Aug 15, 2022	BUY	$204.13 - $302.4 $29,802 - $44,150	146 Added 11.08%	1,464 $313,000
Q1 2022 May 17, 2022	SELL	$255.51 - $362.11 $5,621 - $7,966	-22 Reduced 1.64%	1,318 $374,000
Q4 2021 Feb 18, 2022	BUY	$351.38 - $448.68 $470,849 - $601,231	1,340 New	1,340 $505,000

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.56B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Future Fund LLC, based on Form 13F filings with the SEC.

Stay updated on Future Fund LLC with notifications on news.